BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20733281)

  • 1. Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
    Altenburg J; de Graaff CS; van der Werf TS; Boersma WG
    Respiration; 2011; 81(1):67-74. PubMed ID: 20733281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
    Shinkai M; Henke MO; Rubin BK
    Pharmacol Ther; 2008 Mar; 117(3):393-405. PubMed ID: 18289694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE; Rubin BK
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory properties of antibiotics.
    Tauber SC; Nau R
    Curr Mol Pharmacol; 2008 Jan; 1(1):68-79. PubMed ID: 20021425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide therapy of chronic rhinosinusitis.
    Cervin A; Wallwork B
    Rhinology; 2007 Dec; 45(4):259-67. PubMed ID: 18085018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis.
    Cervin A; Wallwork B
    Otolaryngol Clin North Am; 2005 Dec; 38(6):1339-50. PubMed ID: 16326189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosis.
    Munić V; Banjanac M; Koštrun S; Nujić K; Bosnar M; Marjanović N; Ralić J; Matijašić M; Hlevnjak M; Eraković Haber V
    Pharmacol Res; 2011 Sep; 64(3):298-307. PubMed ID: 21473915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomodulatory properties of macrolides].
    Targowski T; Jahnz-Rózyk K
    Pol Merkur Lekarski; 2008 Nov; 25(149):408-11. PubMed ID: 19177776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory activity of macrolide antibiotics.
    Ianaro A; Ialenti A; Maffia P; Sautebin L; Rombolà L; Carnuccio R; Iuvone T; D'Acquisto F; Di Rosa M
    J Pharmacol Exp Ther; 2000 Jan; 292(1):156-63. PubMed ID: 10604943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide antibiotics as biological response modifiers.
    Rubin BK; Tamaoki J
    Curr Opin Investig Drugs; 2000 Oct; 1(2):169-72. PubMed ID: 11249569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma.
    Hrvacić B; Bosnjak B; Bosnar M; Ferencić Z; Glojnarić I; Eraković Haber V
    Eur J Pharmacol; 2009 Aug; 616(1-3):236-43. PubMed ID: 19560456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients.
    Maimon N; Lipton JH; Chan CK; Marras TK
    Bone Marrow Transplant; 2009 Jul; 44(2):69-73. PubMed ID: 19430505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis.
    Schultz MJ
    J Antimicrob Chemother; 2004 Jul; 54(1):21-8. PubMed ID: 15190022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS; Rubin BK
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents.
    Sugawara A; Sueki A; Hirose T; Nagai K; Gouda H; Hirono S; Shima H; Akagawa KS; Omura S; Sunazuka T
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3373-6. PubMed ID: 21524580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide antibiotics in the treatment of asthma. An update.
    Hernando-Sastre V
    Allergol Immunopathol (Madr); 2010; 38(2):92-8. PubMed ID: 20171003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities.
    van Dijk A; Molhoek EM; Veldhuizen EJ; Bokhoven JL; Wagendorp E; Bikker F; Haagsman HP
    Mol Immunol; 2009 Aug; 46(13):2465-73. PubMed ID: 19524300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.